Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pyloriEradication in Taiwan-Reference-Cited by-同舟云学术

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pyloriEradication in Taiwan

Published:2013 Issue: Volume:2013 Page:1-6
ISSN:1687-6121
Container-title:Gastroenterology Research and Practice
language:en
Short-container-title:Gastroenterology Research and Practice

Author:

Tai Wei-Chen¹,Chiu Chien-Hua²,Liang Chih-Ming¹,Chang Kuo-Chin¹,Kuo Chung-Mou¹,Chiu Yi-Chun¹^ORCID,Wu Keng-Liang¹,Hu Ming-Luen¹,Chou Yeh-Pin¹,Chiou Shue-Shian¹,Chiu King-Wah¹^ORCID,Kuo Chung-Huang¹^ORCID,Hu Tsung-Hui¹,Lin Ming-Tsung¹,Chuah Seng-Kee¹^ORCID

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan

2. Division of General Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan

Publisher

Hindawi Limited

Subject

Gastroenterology,Hepatology

Link

http://downloads.hindawi.com/journals/grp/2013/932478.pdf

Reference36 articles.

1. Effect of Treatment ofHelicobacter pyloriInfection on the Long-term Recurrence of Gastric or Duodenal Ulcer

2. A new look at anti-Helicobacter pylori therapy

3. Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial

4. Is There a Benefit to Extending the Duration of Helicobacter pylori Sequential Therapy to 14 Days?